Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
Top Cited Papers
- 27 September 2016
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 30 (12), 1268-1278
- https://doi.org/10.1177/0269881116662634
Abstract
Acute and enduring adverse effects of psilocybin have been reported anecdotally, but have not been well characterized. For this study, 1993 individuals (mean age 30 yrs; 78% male) completed an online survey about their single most psychologically difficult or challenging experience (worst “bad trip”) after consuming psilocybin mushrooms. Thirty-nine percent rated it among the top five most challenging experiences of his/her lifetime. Eleven percent put self or others at risk of physical harm; factors increasing the likelihood of risk included estimated dose, duration and difficulty of the experience, and absence of physical comfort and social support. Of the respondents, 2.6% behaved in a physically aggressive or violent manner and 2.7% received medical help. Of those whose experience occurred >1 year before, 7.6% sought treatment for enduring psychological symptoms. Three cases appeared associated with onset of enduring psychotic symptoms and three cases with attempted suicide. Multiple regression analysis showed degree of difficulty was positively associated, and duration was negatively associated, with enduring increases in well-being. Difficulty of experience was positively associated with dose. Despite difficulties, 84% endorsed benefiting from the experience. The incidence of risky behavior or enduring psychological distress is extremely low when psilocybin is given in laboratory studies to screened, prepared, and supported participants.Keywords
This publication has 30 references indexed in Scilit:
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybinJournal of Psychopharmacology, 2015
- Experienced Drug Users Assess the Relative Harms and Benefits of Drugs: A Web-Based SurveyJournal of Psychoactive Drugs, 2013
- Use of the Classic Hallucinogen Psilocybin for Treatment of Existential Distress Associated with CancerPublished by Springer Science and Business Media LLC ,2012
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effectsPsychopharmacology, 2011
- Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaireDrug and Alcohol Dependence, 2011
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months laterJournal of Psychopharmacology, 2008
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significancePsychopharmacology, 2006
- An Ethnomycological Review of Psychoactive Agarics in Australia and New ZealandJournal of Psychoactive Drugs, 1991
- Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis (earle) singerJournal of Ethnopharmacology, 1982
- Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, U.S.A.Journal of Ethnopharmacology, 1982